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Both active and passive smoking are regarded as risk factors for various diseases. To darifjr the
effects ofactive andpassivesmoking onplasmavitamin C levels andlipidperoxidation status, we
examined the plasma levels of ascorbic acid (AA), its redox status [ratio ofdehydroascorbate
(DHAA) to totalAA], the levels ofthiobarbiturate reactive substance (TBARS), and the levels of
lipid peroxides (LPO) in smokers, nonsmokers, and nonsmokers regularly exposed to environ-
mental cigarette smoke (passive smokers). The studypopulation consisted of 149 healthy males:
75 active smokers (consumption of> 15 cigarettes/dayformore than 5years), 36 passive smokers
(more than 10 hr/weekexposure to environmentalcigarettesmoke), and38:nonsmokers (no ciga-
rette smoke exposure). Tlhere were no significant diferences in plasma TBARS and LPO levels
among the three groups. Plasma level ofAA, the reduced form ofvitamin C, were significanty
lower in active smokers than in the combined nonsmoking groups (7.2 * 3.5 and 8.4 ± 3.4
p/mL, respectively., p < 0.05).Although no significant differences were found in plasma DHAA
levels among thethree groups, the ratios ofDHAAto totalAAweresignificantly higher in active
and passive smokers than nonexposed nonsmokers (11.2, 10.3, and 7.1%,respectively; pc 0.05).
These results indicate that passive smoking, as well as direct inhalation ofcigarette smoke, affiects
the redox status ofplasmaAA. In passive smokers, the altered redoxstatus ofplasmaAA suggets
an oxidative stress. Key words: ascorbic acid, environmental tobacco smoke, lipid peroxidation,
passive smoking, redox status, tobacco smoke. Environ Health Perspect 108:105-108 (2000).
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Environmental tobacco smoke (ETS) inhala-
tion (passive smoking) as well as direct
inhalation ofsmoke (active smoking) is asso-
ciated with various diseases. Several investi-
gators have reported that ETS exposure leads
to increased risks of atherosclerotic vascular
disease (1,2) and cancer (3). A number of
mechanisms may be involved in the athero-
genesis induced by passive smoking, such as
dysfunction of endothelium (4), altered
lipoprotein profiles in passive smokers (5,6),
increase in oxidizability of low-density
lipoprotein (LDL), and decrease in plasma
ascorbic acid (AA) levels caused by ETS
exposure (7). ETS may play a role in car-
cinogenesis because it contains a number of
carcinogens and because increased levels of
these carcinogens have been found in the
blood and urine ofsmokers (8).
In recent years there has been increasing
evidence that the intake ofdietaryantioxidant
vitamins, such as vitamin C, vitamin E, and
P-carotene, is associated with a decreased risk
of atherosclerosis (9). Smokers have lower
blood levels of these antioxidant vitamins
(10). Vitamin C has antiatherogenic proper-
ties, including inhibition of LDL oxidation
(11,12) and improvement of decreased
endothelial function (13-15). The antioxida-
tive effect of vitamin C is exerted by its
reduced form, AA, whereas its oxidized form,
dehydroascorbic acid (DHAA), is considered
a marker ofoxidative stress, such as smoking
(16) and diabetes mellitus (17). Although the
absolute levels ofplasma AA in passive smok-
ers are lower than those in nonsmokers (18),
it remains undear whether DHAA levels and
the proportion of DHAA to total AA are
altered in passive smokers.
Increased lipid peroxidation products
have been observed in atherosclerotic
plaques (19), and it has been suggested that
smoking could induce atherosclerosis in part
through the formation of oxidatively modi-
fied lipids and/or the generation ofoxidative
stress in the vascular wall. It has not only
been reported that active smoking was asso-
ciated with increased lipid peroxides in plas-
ma (20), but also that ETS exposure affected
plasmalipid peroxidation (7).
To investigate the effects of ETS expo-
sure on oxidative stress in plasma and the
major risk factors for atherosclerotic diseases,
we determined plasma AA, DHAA, lipid
peroxidation products, lipid levels, and other
biochemical parameters in smokers and in
nonsmokers with or without exposure to
ETS.
Methods
Subjects. Subjects included male soldiers or
male employees at the Simofusa Base of the
Japan Maritime Self Defense Force
(Simofusa, Japan). Subjects were examined
by blood and physiologic examinations in
periodical medical checks, and thosewith the
following diseases or abnormal findings were
excluded from the study population: cardio-
vascular and cerebrovascular diseases, acute
and chronic inflammatory diseases, neoplas-
tic diseases, diabetes mellitus, any endocrine
diseases, renal dysfunction, liver dysfunction
except for slight elevations of aspartate
aminotransferases (up to 60 IU/L), abnormal
data in fasting blood glucose (> 120 mg/dL),
and significant excretion of urine glucose.
Subjects taking supplemental vitamins or
routine medicationwere also excluded.
The remaining subjects consisted of 156
healthy males who read, understood, and
answered a questionnaire and signed the
informed consent forms. Smoking habits and
ETS exposure were evaluated by using a
smoking-history questionnaire that allowed
an assessment ofthe hours ofETS exposure
in the worksite and the home. According to
the results of the questionnaire, the subjects
were divided into three groups: 75 active
smokers (self-reported smokers), 36 passive
smokers [self-reported nonsmokers with > 10
hr/week of ETS exposure for > 6 months;
ETS(+)], 38 nonexposed nonsmokers [self-
reported nonsmokers with < 2 hr/week ETS
exposure for > 6 months; ETS(-)]. Seven sub-
jects that did not fit into these classifications
(nonsmokers with between 2 and 10 hr/week
ETS exposure) were excluded from the study
population. The subjects in the three study
groups ranged in age from 35 to 56 years
(41.5 ± 7.2, mean ± SD). Vitamin C intake
ofthe subjects was determined by analysis of
3-day food records just before the day of
blood sampling.
Bloodsampling. After 12 hr fasting and
abstinence from smoking, bloodsampleswere
obtained from the subjects. Bloodwas collect-
ed into vacutainers containing heparin as an
anticoagulant and placed immediately on ice,
and plasma was separated by centrifugation.
Aliquots ofthe plasmasamplesweresubjected
to biochemical analyses, and the remainder
was stored at-800C forfurtherstudy.
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Ascorbateanddebydroascorbate determi-
nation. Plasma samples were immediately
mixed with four volumes of methanol.
Precipitates were removed by centrifugation
(4,000 x g at 4°C for 5 min) and super-
natants were kept at -80°C for up to 2 weeks
until analysis. AA and DHAA levels were
measured by HPLC based on the methods of
Barja et al. (21). Briefly, AAwas separated by
reversed-phase HPLC using an NH2 column
(25 x 0.46 cm, 5 pm particle size; Superco,
Tokyo, Japan) eluted with methanol/40 mM
NaH2PO4 (7:3, vol/vol) at 1.0 mL/min as
the mobile phase and monitored at 265 nm
in an ultraviolet detector. DH-AA levels were
determined by subtracting AA values from
total AA levels after the addition ofdithio-
threitol (50 mM) as a reducing agent. There
was no significant difference in concentra-
tions between the freshly prepared samples
and the identical aliquots stored at-80°C.
Biochemical analyses. Total plasma cho-
lesterol, triglycerides, free cholesterol, and
phospholipids were determined by enzymat-
ic methods using commercially available
enzymatic reagents (Kyowa Medex, Tokyo,
Japan). High-density lipoprotein (HDL)
cholesterol was measured by precipitating
all of the other cholesterol fractions with
phosphotungstate-magnesium (22). LDL
cholesterol was estimated using the formula
reported by Friedewald et al. (23). Plasma
lipid hydroperoxide (LPO) was measured
by using a commercially available kit
(Determiner LPO; Kyowa Medex) based on
a colorimetric method by assessing the reac-
tion ofamethylene blue derivative withlipid
peroxides in the presence of heme com-
pounds (24). Plasma thiobarbiturate reactive
substance (TBARS) levels were determined
by colorimetric assay reported by Buege and
Aust (25). Plasma thiocyanate levels were
determined by the method ofPettigrew and
Fell (26).
Statisticalanalyses. Values were expressed
as the mean ± SD. We used unpaired t-tests
for comparison between groups. Associations
between parameters were determined by
Pearson's product-moment correlation coeffi-
cients. Values withp < 0.05 were considered
significant.
Results
Table 1 shows the characteristics ofthe sub-
jects included in this study, induding age,
body mass index (BMI), blood pressure,
number of cigarettes smoked per day, alco-
hol consumption, and vitamin C intake.
Although alcohol consumption was signifi-
cantly higher in the active smoking (AS)
group than in the nonsmoking (NS) group,
there were no significant differences in age,
BMI, blood pressure, or vitamin C intake
between thegroups.
Biochemical parameters ofblood samples
in each group were assessed (Table 2). Plasma
triglyceride levels were higher in theAS group
than in the NS group. Besides the triglyceride
levels, there were no other significant differ-
ences in fasting blood glucose, uric acid, or
plasma lipid levels. Plasma thiocyanate, a
marker ofsmokingexposure, was significantly
higher not only in theAS group, as compared
to the NS group, but also in the ETS(+)
group, as compared to the ETS(-) group.
There was a significant positive correlation
between plasma thiocyanate levels and cumu-
lativehours ofexposure to ETS in the ETS(+)
group (Figure 1), indicating the reliability of
the questionnaire used to assess ETS expo-
sure. Table 3 shows the levels of plasma AA
and DHAA and the ratio of DHAA to total
AA (%DHAA). Total plasma AA levels did
not differ significantly between the AS
and NS groups or between the ETS(+) and
ETS(-) groups. However, the mean level of
the reduced form ofvitamin C was signifi-
cantlyhigher in the NS group than in theAS
group. There was no significant difference in
AAlevels between the ETS(+) and the ETS(-)
groups. Although absolute DHAA levels were
not significantly different among the groups,
%DHAA was significantly higher in the
AS and ETS(+) groups than in the NS and
ETS(-) groups, respectively. Plasma LPO and
TBARS levels showed no significant differ-
ences amongthegroups (Table4).
Discussion
ETS is related to important medical
consequences, including increased risk of
cardiovascular disease (1,2) and cancer (3).
Several epidemiologic studies investigating
atherosclerotic cardiovascular disease have
been reported in recent years, induding one
estimate ofup to 40,000 excess heart disease
deaths/year attributed to ETS exposure (1).
It is likely that the mechanisms of passive
smoking-induced atherogenesis are similar to
the mechanisms of active smoking-induced
disease. Several studies have investigated the
effects of ETS and its role in atherogenesis,
such as increased thickness of carotid artery
walls in humans (27), enhanced platelet
aggregation (28), altered atherogenic
lipoprotein profile (5,6), and inhibition of
endothelium-dependent vasodilatation (4).
Decreased levels ofantioxidative vitamins
such as vitamins C and E are considered one
ofthe mechanisms for the induction ofather-
osclerosis by smoking. The protective effect
of fruit consumption against atherosclerotic
disease has been well documented in several
epidemiologic studies, suggesting the benefi-
cial contribution of increased vitamin C
intake (29). Kritchevsky et al. (30) reported a
significant inverse relationship between vita-
min C intake and carotid artery wall thick-
ness as evaluated by B-mode ultrasound.
AA, the reduced form ofvitamin C, is an
important cofactor in several enzyme reac-
tions and plays a pivotal role in the defense
against oxidative stress (31,32). Mammalian
cells efficiently regenerate AA from its two-
electron oxidized form, DHAA. The recycling
of DHAA to AA is mediated by glutathione
(33). Kagan et al. (34) reported that AA had
the potential to regenerate ox-tocopherol from
Table 1. Clinical characteristics ofsubjects.
Characteristics
Age(years)
BMIlkg/m2)
Systolic blood pressure (mmHg)
Diastolic blood pressure (mmHg)
Cigarettes Ino./day)
Alcohol consumption (g/week)
Vitamin C intake(mg/day)
AS
(n=75)
42.6 ± 5.7
24.0 ± 2.5
124.6 ± 14.9
78.1 ± 11.7
20.9 ± 7.1
388 ± 427
112 ±65
NS
(n=74)
43.0 ± 5.8
23.9 ± 2.3
125.2 ± 13.6
79.3 ± 10.4
166 ± 199*
120 ± 78
NS
ETS(-) ETS(+)
(n=38) (n=36)
44.0 ± 6.5 42.0 ±4.8
23.7± 1.8 24.1 ±2.5
124.1 ± 13.4 126.4± 13.9
78.7± 9.6 79.9± 11.2
138± 182 191 ±214
119±57 122±63
Abbreviations: AS, active smokers; NS, nonsmokers, BMI, body mass index.
Values represent mean ± SD. Differences between the groups were compared by unpaired Student's t-test.
*p<0.001, AS versus NS.
Table 2. Biochemical parameters of plasma.
Biochemical parmeters
Fasting blood glucose(mg/dL)
Uricacid(mg/dL)
Total cholesterol (mg/dL)
HDL cholesterol (mg/dL)
LDL cholesterol (mg/dL)
Triglycerides (mg/dL)
Phospholipids (mg/dL)
Thiocyanate (pmol/L)
AS
(n=75)
97.4± 10.0
6.1 ± 1.1
202.4 ± 32.5
55.6 ± 15.6
116.6 ±30.8
150.9± 113.2
218.9 ± 84.2
78.2 ± 33.9
NS
(n=74)
101.4± 15.0
5.7 ± 1.3
198.8 ± 29.3
57.0 ± 14.1
121.1 ± 26.8
103.4 ± 56.9**
213.0 ± 74.1
23.0 ± 20.3'
NS
ETS(-) ETS(+)
(n=38) (n=36)
101.1 ± 18.7 101.8±9.5
5.8± 1.4 5.7± 1.3
196.7 ± 28.9 201.2 ± 30.3
58.5± 16.0 55.4± 11.8
116.6±22.6 126.0±30.3
107.6 ± 65.6 98.9 ±46.1
205.1 ± 75.3 221.1 ± 73.0
18.1 ± 10.6 28.0± 26.2##
Values represent mean ± SD. Differences between the groups were compared by unpaired Student's t-test.
**p< 0.01 and#p< 0.001, AS versus NS.""p<0.05,ETS(-) versusETS(+).
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the a-tocopheryl radical with the subsequent
change of AA to DHAA. Thus AA, either
directly or indirectly, contributes to an
antioxidative effect. DHAA is believed to be a
marker of oxidative stress caused by diabetes
mellitus (17) or smoking (16). Although ciga-
rette smoke affects the redox status ofplasma
AA, forming DHAA (35), several investiga-
tors have also reported unfavorable effects of
DHAA itself. Patterson (36) reported that
DHAA had cytotoxic and diabetogenic
effects, and Stait and Leake (11) reported that
whereas AA inhibited LDL oxidation by cop-
per, DHAAaccelerated this process.
We found decreased absolute levels of
AA and increased %DHAA in theAS group,
which is consistent with previous studies
(16). Because there were no differences in
vitamin C intake among the groups, the
decrease of plasma AA caused by cigarette
smoking appears to occur predominantly via
mechanisms independent ofdietary vitamin
C intake levels (37). Although cigarette
smoke directly induces the depletion of
vitamin C (35), the kinetic studies ofKallner
et al. (38) showed an increased turnover of
vitamin C in smokers. Therefore, the low
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Figure 1. Correlation between plasma thiocyanate
levels and cumulative hours of ETS exposure in
the ETS(+) group. r= 0.481, p= 0.003.
levels ofplasmavitamin C in smokers may be
due to increased consumption by oxidants
contained in cigarette smoke. Moreover,
%DHAAlevels were higher in the AS group,
implying that smoking could induce oxida-
tive stress. Of further interest is the finding
that the %DHAA in passive smoking sub-
jects, although it is lower than that observed
in theAS group, was still significantly higher
than that in nonsmokers without ETS expo-
sure. Several investigators have suggested
that plasma thiocyanate is a good marker of
passive smoking (39). We also observed sig-
nificantly higher plasma thiocyanate levels in
passive smokers and a positive correlation
between plasma thiocyanate and cumulative
hours of ETS exposure, indicating that
sidestream smoke inhaled indirectly could
induce biologic reactions. Davis et al. (28)
reported that toxic compounds were present
in sidestream smoke, which contributes
more to ETS than mainstream smoke.
Although the actual levels of oxidants con-
tained in environmental polluted air were
unclear, it was suggested that inhalation of
sidestream smoke could increase the oxida-
tion of AA at least as well as mainstream
smoke (because of the radical properties of
AA). We found no significant relationship
between %DHAA and any ofthe examined
passive or active smoking parameters such as
cumulative hours of ETS exposure, plasma
thiocyanate, or the number of cigarettes
smoked per day (data not shown). However,
it has been suggested that the concentrations
and the species of oxidants contained in
mainstream smoke and environmental air
are heterogeneous (40).
We observed that the plasma triglyceride
levels in the smokers were higher than those
in nonsmokers, whereas HDL cholesterol
levels were not different between the two
groups. These results might be due to a
Table3. Plasma total AA, reduced AA, DHAA, and proportion of DHAA relative tototal AA(%DHAA).
NS
AS NS ETS(-) ETS(+)
Plasma (n=75) (n= 74) (n= 38) (n=36)
Total AA(pg/mL) 8.12 + 3.87 9.13 + 3.49 9.44 + 3.92 8.80 + 2.98
Reduced AA (pg/mL) 7.22 + 3.48 8.38 +3.36* 8.80 ± 3.77 7.92 + 2.84
DHAA(pg/mL) 0.90 ± 0.70 0.76 + 0.64 0.64 + 0.65 0.88 +0.62
%DHAA (%) 11.2 ± 6.96 8.62 +6.77* 7.07 + 6.24 10.3 +7.00**
Values represent mean ± SD. Differences between the groups were compared by unpaired Student's t-test.
*p<0.05, AS versus NS. **p<0.05,ETS(-) versusETS(+).
Table 4. Plasma LPO and TBARS.
NS
AS NS ETS(-) ETS(+)
Plasma (n=75) (n= 74) (n=38) (n= 36)
LPO (nmol/L) 16.6 ± 8.0 15.6 ± 6.4 15.6 ± 6.6 15.6 +6.4
LPO/total lipids (nmol/g) 51.3 ± 27.3 56.6 + 28.3 58.1 ± 29.9 54.9 ± 27.3
TBARS (nmol/L) 5.42 + 2.32 4.94 ± 0.95 4.89 + 0.97 4.99 ± 0.94
Total lipids indicate the value of sum of total cholesterol, triglyceride, and phopholipids. Values represent mean ± SD.
Differences between the groups were compared by unpaired Student's t-test.
greater consumption ofalcohol in the smokers
than in the nonsmokers. According to our
questionnaire, there was a high prevalence of
alcohol drinkers in the smoking group. The
levels ofplasma triglyceride were significant-
ly correlated with alcohol consumption in
our subjects. In addition, %DHAA had no
association with plasma triglyceride levels or
alcohol consumption when a multiple
regression analysis was performed for all sub-
jects (data not shown). Therefore, plasma
triglyceride levels and alcohol consumption
were not likely to be the main causes of the
difference in %DHAA between the groups.
Oxidative modification ofLDL has been
implicated in the pathogenesis ofatheroscle-
rosis (41). Lipid peroxidation products are
reportedly found in human atherosclerotic
lesions (19). Plasma from smokers contains
more lipid peroxides (20), and LDL from
smokers is more susceptible to oxidative
modification than that from nonsmokers
(42). Additionally, Valkonen and Kuusi (7)
recently reported increased LDL oxidizabili-
ty in passive smokers. In the present study
we found no significant differences in plas-
ma TBARS and lipid peroxide levels among
the subject groups. Frei et al. (32,35) report-
ed that lipid peroxidation in plasma
occurred after complete depletion ofvitamin
C. Additionally, Harats et al. (42) showed
that there was no difference in TBARS levels
in LDL isolated from smokers and non-
smokers; however, the LDL from smokers
was more readily oxidized than the LDL
from nonsmokers. Therefore, the decreased
plasma vitamin C, increased %DHAA, and
unaffected plasma lipid peroxidation prod-
ucts found in the present data are consistent
with the results ofthese previous studies.
We observed that passive smoking, as
well as direct inhalation of cigarette smoke,
affected the redox status of plasma vitamin
C. This indicates that both active and pas-
sive smoking could induce the generation of
oxidative stress. Unfavorable changes in the
redox status of plasma vitamin C may be a
mechanism ofthe induction ofatherogenesis
induced bypassive smoking.
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